BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 24041958)

  • 1. Decipher the mechanisms of rabbit's low susceptibility to prion infection.
    Yuan Z; Zhao D; Yang L
    Acta Biochim Biophys Sin (Shanghai); 2013 Nov; 45(11):899-903. PubMed ID: 24041958
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling the key to the resistance of canids to prion diseases.
    Fernández-Borges N; Parra B; Vidal E; Eraña H; Sánchez-Martín MA; de Castro J; Elezgarai SR; Pumarola M; Mayoral T; Castilla J
    PLoS Pathog; 2017 Nov; 13(11):e1006716. PubMed ID: 29131852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct effects of Cu2+-binding on oligomerization of human and rabbit prion proteins.
    Lin K; Yu Z; Yu Y; Liao X; Huang P; Guo C; Lin D
    Acta Biochim Biophys Sin (Shanghai); 2015 Oct; 47(10):842-50. PubMed ID: 26350098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asparagine and glutamine ladders promote cross-species prion conversion.
    Kurt TD; Aguilar-Calvo P; Jiang L; Rodriguez JA; Alderson N; Eisenberg DS; Sigurdson CJ
    J Biol Chem; 2017 Nov; 292(46):19076-19086. PubMed ID: 28931606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alkylating antitumor drug mechlorethamine conceals a structured PrP domain and inhibits in vitro prion amplification.
    Zhou X; Bi H; Wong J; Shimoji M; Wang Y; Yuan J; Xiao X; Wang GX; Zou WQ
    J Toxicol Environ Health A; 2011; 74(22-24):1493-503. PubMed ID: 22043910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper induces increased beta-sheet content in the scrapie-susceptible ovine prion protein PrPVRQ compared with the resistant allelic variant PrPARR.
    Wong E; Thackray AM; Bujdoso R
    Biochem J; 2004 May; 380(Pt 1):273-82. PubMed ID: 14969585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of possible prion protein self-interaction domains using peptide arrays.
    Rigter A; Langeveld JP; Timmers-Parohi D; Jacobs JG; Moonen PL; Bossers A
    BMC Biochem; 2007 Apr; 8():6. PubMed ID: 17430579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased proportions of C1 truncated prion protein protect against cellular M1000 prion infection.
    Lewis V; Hill AF; Haigh CL; Klug GM; Masters CL; Lawson VA; Collins SJ
    J Neuropathol Exp Neurol; 2009 Oct; 68(10):1125-35. PubMed ID: 19918124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning and sequence analysis of prion protein gene in Xiji donkey in China.
    Zhang Z; Wang R; Xu L; Yuan F; Zhou X; Yang L; Yin X; Xu B; Zhao D
    Gene; 2013 Oct; 529(2):345-50. PubMed ID: 23954254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residues surrounding the glycosylphosphatidylinositol anchor attachment site of PrP modulate prion infection: insight from the resistance of rabbits to prion disease.
    Nisbet RM; Harrison CF; Lawson VA; Masters CL; Cappai R; Hill AF
    J Virol; 2010 Jul; 84(13):6678-86. PubMed ID: 20427543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion protein aggregation and fibrillogenesis in vitro.
    Stöhr J
    Subcell Biochem; 2012; 65():91-108. PubMed ID: 23225001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular bases of prion diseases].
    Rać M; Rać M
    Ann Acad Med Stetin; 2006; 52(3):5-13. PubMed ID: 17385343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
    Liemann S; Glockshuber R
    Biochemistry; 1999 Mar; 38(11):3258-67. PubMed ID: 10079068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D159 and S167 are protective residues in the prion protein from dog and horse, two prion-resistant animals.
    Sanchez-Garcia J; Fernandez-Funez P
    Neurobiol Dis; 2018 Nov; 119():1-12. PubMed ID: 30010001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring prion protein stability by NMR.
    Julien O; Graether SP; Sykes BD
    J Toxicol Environ Health A; 2009; 72(17-18):1069-74. PubMed ID: 19697241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural factors underlying the species barrier and susceptibility to infection in prion disease.
    Sweeting B; Khan MQ; Chakrabartty A; Pai EF
    Biochem Cell Biol; 2010 Apr; 88(2):195-202. PubMed ID: 20453922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction of glutamines into the B2-H2 loop promotes prion protein conversion.
    Avbelj M; Hafner-Bratkovič I; Jerala R
    Biochem Biophys Res Commun; 2011 Oct; 413(4):521-6. PubMed ID: 21910969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the structural stability of rabbit prion probed by molecular dynamics simulations.
    Zhang J
    J Biomol Struct Dyn; 2009 Oct; 27(2):159-62. PubMed ID: 19583441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.